Quidel’s Stock Soars In Response To Avian Flu Threat, Gains 22.7% In October
This article was originally published in The Gray Sheet
Executive Summary
Anticipation of the flu season and the threat of a global pandemic fueled Wall Street's attention on influenza test manufacturer Quidel in October
You may also be interested in...
NuVasive Boosts Artificial Disc Development, Stock; OTC Index Rises 15%
NuVasive will use profits gained from a series of 510(k)-cleared spinal devices to fuel artificial disc and nucleus replacement development in 2006
NuVasive Boosts Artificial Disc Development, Stock; OTC Index Rises 15%
NuVasive will use profits gained from a series of 510(k)-cleared spinal devices to fuel artificial disc and nucleus replacement development in 2006
Medical Services Int’l Poised To Be First Marketer Of Bird Flu Test In China
A Canadian diagnostic firm that specializes in developing cost-effective tests for third world countries says it will be the first-to-market in China with a rapid diagnostic test for avian influenza Type A virus, or "bird flu.